Intrinsic disorder in cell-signaling and cancer-associated proteins

Lilia M Iakoucheva1, Celeste J Brown, J David Lawson

  • 1Department of Biochemistry and Biophysics, School of Molecular Biosciences, Washington State University, Pullman, WA 99164-4660, USA.

Insights

Intrinsically disordered proteins are prevalent in cell signaling and cancer regulation. This study reveals significantly higher disorder in cancer-associated and signaling proteins compared to ordered protein controls.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Bioinformatics

Background:

  • Intrinsically disordered proteins (IDPs) are increasingly recognized for their roles in cellular processes.
  • Understanding the prevalence of IDPs in signaling and cancer is crucial for biological insights.

Purpose of the Study:

  • To investigate the generalized involvement of intrinsic disorder in cell signaling and cancer.
  • To compare disorder levels in cancer-associated proteins (HCAP) and signaling proteins (AfCS) against control datasets.

Main Methods:

  • Utilized the PONDR VL-XT neural network predictor to identify intrinsically disordered regions in protein datasets.
  • Analyzed four datasets: HCAP, AfCS, eukaryotic proteins (EU_SW), and ordered protein segments (O_PDB_S25).
  • Extended disorder analysis to 11 additional functional categories of human proteins.

Main Results:

  • Predicted significantly higher intrinsic disorder in HCAP (79%) and AfCS (66%) compared to EU_SW (47%) and O_PDB_S25 (13%).
  • Proteins in metabolism, biosynthesis, and transport showed twofold less disorder than regulatory and cancer-associated proteins.
  • Cancer-associated proteins exhibited a lack of structural information in the Protein Data Bank, correlating with predicted disorder.

Conclusions:

  • Intrinsically unstructured proteins play critical roles in cell signaling, regulation, and cancer.
  • Coupled folding and binding is a common mechanism for IDPs in these processes.
  • The findings support a widespread role for intrinsic disorder in cancer and signaling pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...